Can an antibody 'cocktail' prevent COVID-19 infection?
In a new clinical trial, UC Davis Health will test the efficacy and safety of REGN-COV2 (a monoclonal antibody mixture) in the prevention of COVID-19 in adults with the infection. The drug was recently administered to President Donald Trump as part of a treatment for SAR-CoV-2 infection. It is still in clinical trials as a potential treatment and prevention for COVID-19.
Stuart Cohen, chief of infectious diseases at UC Davis Health and the hospital's director of epidemiology and infection prevention, will oversee the clinical trial and help recruit participants.
Cohen said, "We at UC Davis Health are excited to participate in this clinical trial and to study antibodies that have been used in the past to prevent many viral infections, such as hepatitis B." "We will be testing the ability of REGN-COV2 to prevent COVID-19 infection in people who are already in close contact with confirmed patients, such as family members,"
You May Interested In
2026-08-27
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Which Protein Is Present In Covid 19
-
Which Is The Best Covid Vaccine In The World
-
Interpretation Of Omicron Covid Variant Symptoms
-
A Look At The Worst Hit Covid Countries
-
Nitric Oxide Nasal Spray Prevents Spread of Coronavirus, Clinical Trials Show
-
'Delta MayJust Be A Warning', New Variant Of COVID-19 May Emerge
-
What Other Vaccines Use mRNA And The Application Of Homogeneous Technology In mRNA Vaccine And Drug Development.
-
Does Vaccine Protect Against Omicron? Zhang Wenhong : Vaccination Booster Is Still An Effective Tool To Deal With Omicron
-
Shanghai Company's Self-Developed COVID-19 mRNA Vaccine Approved For Clinical Trials And mRNA Vaccines Animal Trials
-
mRNA Vaccine Production Process : LNP Delivery Technology
Recommend Reading
-
![Wuxi Yinda Nylon Acquires German Century-Old Chemical Giant Perlon]()
Wuxi Yinda Nylon Acquires German Century-Old Chemical Giant Perlon
-
![FDA Grants Accelerated Approval to Bristol Myers Squibb’s ZENBEXUS, Launching First CELMoD Therapy in Multiple Myeloma]()
FDA Grants Accelerated Approval to Bristol Myers Squibb’s ZENBEXUS, Launching First CELMoD Therapy in Multiple Myeloma
-
![Synthomer Sells Its Last Upstream Chemical Business]()
Synthomer Sells Its Last Upstream Chemical Business
-
![FDA Approves Lantheus’ TAUKLARIFY for Alzheimer’s Tau PET Imaging]()
FDA Approves Lantheus’ TAUKLARIFY for Alzheimer’s Tau PET Imaging
-
![China’s Acrylic Emulsion Leaders Raise Prices by Up to 15% as Monomer Costs Surge]()
China’s Acrylic Emulsion Leaders Raise Prices by Up to 15% as Monomer Costs Surge
-
![Cost Floor and Demand Constraints: Dichloromethane in Volatile Consolidation]()
Cost Floor and Demand Constraints: Dichloromethane in Volatile Consolidation
-
![China Releases 15th Five-Year Carbon-Peaking Action Plan, Pushing Coal Chemicals into a Mandatory Low-Carbon Upgrade Cycle]()
China Releases 15th Five-Year Carbon-Peaking Action Plan, Pushing Coal Chemicals into a Mandatory Low-Carbon Upgrade Cycle
-
![This week, the price of polyester bottle chips fluctuated and rose]()
This week, the price of polyester bottle chips fluctuated and rose
-
![Premium Global Chemical Sourcing Requests (18-21Jun, 2026)]()
Premium Global Chemical Sourcing Requests (18-21Jun, 2026)
-
![This week, the caustic soda price was weak (4.13-4.17) in China]()
This week, the caustic soda price was weak (4.13-4.17) in China
